EAM Investors’s T2 Biosystems, Inc TTOO Stock Holding History

EAM Investors’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-42	Closed	-$1.63M	–	384
2018 Q2	$1.63M	Buy	+42	New	+$1.59M	0.26%	168

Other funds holding TTOO

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EAM Investors's TTOO Position: Q3 2018 in Review

EAM Investors sold out of T2 Biosystems, Inc (TTOO) in Q3 2018, closing a stake of 42 shares — an estimated $1.63M sold.

EAM Investors first reported a position in TTOO in Q2 2018 and held it in 1 quarter. The position peaked at $1.63M in Q2 2018. 85 funds tracked by Wall St. Rank hold TTOO as of Q3 2018.

EAM Investors reported no remaining T2 Biosystems, Inc position as of Q3 2018 after selling out during the quarter.
EAM Investors sold 42 T2 Biosystems, Inc shares in Q3 2018, an estimated $1.63M.
EAM Investors first reported a position in T2 Biosystems, Inc in Q2 2018 and held it in 1 quarter.
EAM Investors's T2 Biosystems, Inc position peaked at $1.63M in Q2 2018.
85 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q3 2018.

Based on EAM Investors's 13F filing for Q3 2018, filed 8 Nov 2018.